English | Español

Biospace
Patient Daily | Feb 26, 2026

Atara stock rises after report questions FDA’s rejection of cell therapy
Patient Daily | Feb 25, 2026

LB Pharma navigates tough markets for successful IPO after promising schizophrenia drug data
Patient Daily | Feb 25, 2026

Creative financing models emerge as key support for rare disease drug development
Patient Daily | Feb 24, 2026

FDA maintains support for mRNA vaccine development without public funding
Patient Daily | Feb 23, 2026

CDC left without permanent leader following Jim O’Neill’s departure
Patient Daily | Feb 23, 2026

Moderna faces delays bringing mRNA-based flu shots to US after FDA decision
Patient Daily | Feb 23, 2026

DIA explores integration of artificial intelligence into regulatory review at annual meeting
Patient Daily | Feb 23, 2026

Policy changes threaten US leadership in biotechnology innovation

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research